# Cirrhosis

## Definition & Classification

**Cirrhosis**: A late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, including chronic viral hepatitis, alcohol misuse, and nonalcoholic fatty liver disease. The scarring replaces normal liver tissue and impairs liver function.

### Classification Systems

**Child-Pugh Classification**:
- **Class A**: 5-6 points (Compensated, well-functioning liver)
- **Class B**: 7-9 points (Significant functional compromise)
- **Class C**: 10-15 points (Decompensated, severe liver dysfunction)

**Child-Pugh Scoring Components**:
1. Serum bilirubin
2. Serum albumin
3. Prothrombin time/INR
4. Presence of ascites
5. Hepatic encephalopathy

**MELD Score (Model for End-Stage Liver Disease)**:
- Score range: 6-40
- Based on: Bilirubin, creatinine, INR, and sodium levels
- Used for liver transplant prioritization

**Etiology Classification**:
- **Alcoholic liver disease** (Alcohol-related liver disease, ALD)
- **Viral hepatitis** (Hepatitis B, Hepatitis C)
- **Nonalcoholic steatohepatitis** (NASH)
- **Autoimmune hepatitis**
- **Primary biliary cholangitis** (PBC)
- **Primary sclerosing cholangitis** (PSC)
- **Hereditary hemochromatosis**
- **Wilson's disease**
- **Alpha-1 antitrypsin deficiency**
- **Cardiac cirrhosis** (from right-sided heart failure)
- **Cryptogenic cirrhosis** (unknown cause)

**Decompensation Status**:
- **Compensated**: No history of ascites, variceal bleeding, jaundice, or encephalopathy
- **Decompensated**: Presence of one or more complications (ascites, variceal bleeding, jaundice, or encephalopathy)

## Required Evidence

### Minimum Documentation

1. **Diagnostic confirmation**:
   - Method of diagnosis (biopsy, imaging, clinical)
   - Etiology of cirrhosis
   - Date of diagnosis
   - Child-Pugh classification
   - MELD score (if available)

2. **Laboratory values**:
   - Liver function tests (AST, ALT, bilirubin, alkaline phosphatase, GGT)
   - Albumin, total protein
   - Prothrombin time/INR
   - Complete blood count (platelets, WBC, RBC)
   - Renal function (BUN, creatinine)
   - Alpha-fetoprotein (AFP)

3. **Clinical assessment**:
   - Presence/absence of ascites
   - Presence/absence of hepatic encephalopathy
   - History of variceal bleeding
   - Evidence of portal hypertension
   - Nutritional status

4. **Treatment information**:
   - Current medications
   - Alcohol abstinence (if alcohol-related cirrhosis)
   - Antiviral therapy (if viral hepatitis)
   - Diuretic therapy (if ascites)
   - Beta-blocker therapy (if varices)
   - History of paracentesis
   - History of TIPS procedure (Transjugular Intrahepatic Portosystemic Shunt)

5. **Imaging studies**:
   - Ultrasound, CT, or MRI findings
   - Evidence of hepatocellular carcinoma screening
   - Portal vein patency
   - Spleen size

### Additional Evidence for Complex Cases

- Liver biopsy reports
- Endoscopy reports (for varices)
- Hepatology consultation notes
- Transplant evaluation status (if applicable)
- Detailed alcohol use history (for alcoholic cirrhosis)
- Hepatocellular carcinoma surveillance results

## Rating Guidelines

### Alcoholic Cirrhosis

| Child-Pugh Class | Duration of Alcohol Abstinence | Rating |
|------------------|--------------------------------|--------|
| A | <1 year | Table 6-8 or Postpone |
| A | 1-2 years | Table 5-7 |
| A | 2-5 years | Table 4-6 |
| A | >5 years | Table 3-5 |
| B | <2 years | Postpone or Decline |
| B | 2-5 years | Table 7-9 |
| B | >5 years | Table 6-8 |
| C | Any | Decline |

**Modifying Factors**:
- Documented attendance at support programs: -1 table
- History of relapse: +2 tables or Decline
- Abnormal but stable liver function tests: No change
- Worsening liver function tests: +1 table or Postpone
- Age >60 with stable Child-Pugh A >5 years: -1 table
- Comorbid conditions affecting liver: +1 to 2 tables

### Viral Hepatitis Cirrhosis (B or C)

| Child-Pugh Class | Viral Status | Treatment Status | Rating |
|------------------|--------------|------------------|--------|
| A | Undetectable | Sustained virologic response >24 weeks | Table 4-6 |
| A | Undetectable | Sustained virologic response >1 year | Table 3-5 |
| A | Detectable | On treatment | Table 5-7 |
| A | Detectable | No treatment | Table 6-8 |
| B | Undetectable | Sustained virologic response >1 year | Table 6-8 |
| B | Detectable | On treatment | Table 8+ or Postpone |
| B | Detectable | No treatment | Postpone or Decline |
| C | Any | Any | Decline |

**Modifying Factors**:
- Advanced age at development of cirrhosis (>60): -1 table
- HBV with suppression >3 years: -1 table
- HCV with SVR >3 years: -1 table
- History of hepatocellular carcinoma: Decline
- Coinfection with HIV: +2 tables to Decline

### NASH/NAFLD Cirrhosis

| Child-Pugh Class | Metabolic Control | Rating |
|------------------|-------------------|--------|
| A | Well-controlled metabolic factors | Table 4-6 |
| A | Partially controlled metabolic factors | Table 5-7 |
| A | Poorly controlled metabolic factors | Table 6-8 |
| B | Well-controlled metabolic factors | Table 7-9 |
| B | Partially/poorly controlled metabolic factors | Table 8+ or Decline |
| C | Any | Decline |

**Modifying Factors**:
- Weight reduction >10%: -1 table
- Diabetes control (HbA1c <7%): -1 table
- Lipid control: -1 table
- Progressive obesity: +1 table
- Worsening diabetes: +1 table
- Significant weight fluctuations: +1 table

### Other Causes of Cirrhosis (Autoimmune, PBC, PSC, Genetic)

| Child-Pugh Class | Disease Control | Rating |
|------------------|-----------------|--------|
| A | Well-controlled | Table 4-6 |
| A | Partially controlled | Table 5-7 |
| A | Poorly controlled | Table 6-8 |
| B | Well-controlled | Table 7-9 |
| B | Partially/poorly controlled | Table 8+ or Decline |
| C | Any | Decline |

**Modifying Factors**:
- Stable disease >3 years: -1 table
- Progressive disease despite treatment: +1 to 2 tables
- Age >60 with stable Child-Pugh A: -1 table
- Adequate specialist follow-up: -1 table

### Post-Transplant Cirrhosis

| Post-Transplant Period | Evidence of Recurrent Disease | Rating |
|------------------------|-------------------------------|--------|
| <1 year | Any | Postpone |
| 1-3 years | No | Table 6-8 |
| 1-3 years | Yes | Table 8+ or Decline |
| >3 years | No | Table 5-7 |
| >3 years | Mild | Table 6-8 |
| >3 years | Significant | Table 8+ or Decline |

## Postpone/Decline Criteria

### Postpone

1. Recent diagnosis (<6 months) without established disease staging
2. Recent decompensation (<12 months)
3. Hospitalization for cirrhosis complications within past 6 months
4. Recent change in antiviral therapy (<6 months)
5. Pending transplant evaluation
6. Alcohol use within past 12 months for alcoholic cirrhosis
7. Unstable or rapidly worsening liver function tests
8. Recent development of complications (ascites, encephalopathy)
9. Recent TIPS procedure (<6 months)

### Decline

1. Child-Pugh Class C
2. MELD score >15
3. History of hepatorenal syndrome
4. Current hepatic encephalopathy
5. Refractory ascites
6. Recurrent variceal bleeding
7. Hepatopulmonary syndrome
8. Portopulmonary hypertension
9. Hepatocellular carcinoma
10. Active alcohol use with alcoholic cirrhosis
11. Listed for liver transplantation

## Laboratory Considerations

| Test | Significance | Underwriting Interpretation |
|------|-------------|----------------------------|
| **Bilirubin** | Liver's ability to process waste | Progressive elevation suggests worsening function |
| **Albumin** | Liver's synthetic function | Low levels suggest poor prognosis |
| **INR/PT** | Clotting factor production | Elevated values indicate decreased synthetic function |
| **AST/ALT** | Hepatocellular injury | May be normal or minimally elevated in established cirrhosis |
| **Alkaline phosphatase** | Biliary function | Elevation suggests cholestasis |
| **GGT** | Biliary function/alcohol use | Elevated in most liver disease, very high in alcohol use |
| **Platelet count** | Portal hypertension | Low count suggests hypersplenism from portal hypertension |
| **Sodium** | Fluid/electrolyte balance | Hyponatremia indicates poor prognosis |
| **Creatinine** | Kidney function | Elevation suggests hepatorenal syndrome or other renal issues |
| **AFP** | Tumor marker | Elevation may suggest hepatocellular carcinoma |

## Comorbidity Factors

The following conditions may increase cirrhosis ratings:

| Comorbidity | Rating Adjustment |
|-------------|-------------------|
| Diabetes mellitus | +1 to 2 tables |
| Chronic kidney disease | +1 to 3 tables |
| Obesity | +1 to 2 tables |
| Alcohol use (for non-alcoholic cirrhosis) | +1 to 3 tables |
| HIV coinfection | +2 to 4 tables |
| Heart failure | +2 to 3 tables |
| Hereditary hemochromatosis | +1 table |
| Alpha-1 antitrypsin deficiency | +1 table |
| Autoimmune disorders | +1 to 2 tables |
| Chronic infections | +1 table |

## Improvement Factors

Ratings may be improved with:

1. **Disease stability**:
   - Stable Child-Pugh score for >2 years
   - Stable MELD score for >2 years
   - No progression in fibrosis on repeated testing
   - Stable liver function tests

2. **Etiology control**:
   - Sustained virologic response for viral hepatitis
   - Long-term alcohol abstinence (>5 years)
   - Control of metabolic factors for NASH
   - Immunosuppression control for autoimmune causes

3. **Risk factor modification**:
   - Weight management
   - Diabetes control
   - Avoidance of hepatotoxic medications
   - Vaccination against hepatitis A and B (if not immune)
   - Regular specialist follow-up

4. **Absence of complications**:
   - No ascites
   - No encephalopathy
   - No varices on endoscopy
   - Normal renal function

## Special Considerations

### Cirrhosis with Portal Hypertension but No Decompensation

| Feature | Significance | Rating Impact |
|---------|-------------|---------------|
| Varices (no bleeding) | Indicates portal hypertension | +1 table |
| Splenomegaly | Indicates portal hypertension | +1 table |
| Mild thrombocytopenia | Indicates hypersplenism | +1 table |
| On prophylactic beta-blockers | Preventive medication | No impact |
| Mild portal hypertensive gastropathy | Early sign | +1 table |

### Cirrhosis in Older Adults (>70 years)

| Child-Pugh Class | Duration of Stability | Rating |
|------------------|----------------------|--------|
| A | >3 years stable | Table 3-5 |
| A | >5 years stable | Table 2-4 |
| B | >3 years stable | Table 6-8 |
| B | >5 years stable | Table 5-7 |
| C | Any | Decline |

### Incidentally Discovered Cirrhosis

For cirrhosis discovered incidentally on imaging without clinical symptoms:

| Child-Pugh Class | Duration of Monitoring | Rating |
|------------------|------------------------|--------|
| A | <1 year | Table 5-6 |
| A | >1 year, stable | Table 3-5 |
| B | Any | Rate as symptomatic cirrhosis |

### Compensated Advanced Chronic Liver Disease (cACLD)

For non-invasively diagnosed early cirrhosis (e.g., by elastography):

| Elastography Result | Risk Factors | Rating |
|--------------------|--------------|--------|
| Borderline (12.5-15 kPa) | No additional risk factors | Table 3-4 |
| Borderline (12.5-15 kPa) | With risk factors | Table 4-5 |
| Definite (>15 kPa) | No complications | Table 4-6 |
| Definite (>15 kPa) | With complications | Table 6-8 |

## References

1. American Association for the Study of Liver Diseases (AASLD) Practice Guidelines
2. European Association for the Study of the Liver (EASL) Clinical Practice Guidelines
3. Child-Pugh Classification System
4. Model for End-Stage Liver Disease (MELD) Scoring System
5. Society of Actuaries Mortality Studies on Cirrhosis and Liver Disease